Summary
The effects of acute oral administration of the antiserotoninergic drugs methysergide (3 mg) and metergoline (4 mg) on basal, submaximal (0.6 µg/kg i. m.) and maximal (6 µg/kg) pentagastrinstimulated gastric acid secretion, as well as on basal and food-induced gastrin release, have been evaluated in healthy volunteers. Methysergide significantly increased basal and submaximal pentagastrin-stimulated gastric acid secretion, and metergoline significantly inhibited gastric acidity in all experiments. Basal and stimulated serum gastrin concentrations were not modified by either drug. The effect of methysergide on gastric acid secretion was opposed to that of serotonin and was probably dependent on its antiserotoninergic action, but the decrease in gastric acidity caused by metergoline is not easily explained. Although the effect is similar to that of a dopamine infusion, it does not depend on dopamine receptor stimulation, since it was not influenced by pretreatment with metoclopramide. It is suggested that it might be due to the weak anticholinergic and/or antihistaminic properties of metergoline.
Similar content being viewed by others
References
Resnick, R. H., Gray, S. J.: Distribution of serotonin (5-hydroxytryptamine) in the human gastrointestinal tract. Gastroenterology41, 119–121 (1961)
Garattini, S., Valzelli, L.: Serotonin. Amsterdam: Elsevier 1965
Erspamer, V.: Occurrence of indolealkylamine in nature. In: Handbook of experimental pharmacology. Vol. XIX. 5-Hydroxytryptamine and related indolealkylamines. V. Erspamer (ed.), pp. 132–181. Berlin, Heidelberg, New York: Springer 1966
Thompson, J. H.: Serotonin and the alimentary tract. Res. Commun. Chem. Pathol. Pharmacol.2, 687–781 (1971)
Hano, J., Bugajski, J., Danek, L., Wantuch, C.: The influence of serotonin on insulin-stimulated gastric secretion, blood glucose and serum electrolyte levels in the unanesthetized rat. Arch. Int. Pharmacodyn. Ther.216, 28–39 (1975)
Bugajski, J., Hano, J., Danek, L., Wantuch, C.: The action of serotonin on basal gastric secretion in the conscious rat after intraventricular and intraperitoneal administration. Arch. Int. Pharmacodyn. Ther.225, 29–38 (1977)
Jaffe, B. M., Kopen, D. F., Lazan, D. W.: Endogenous serotonin in the control of gastric acid secretion. Surgery82, 156–163 (1977)
Haverback, B. J., Bogdanski, D., Hogben, C. A. M.: Inhibition of gastric acid secretion in the dog by the precursor of serotonin, 5-hydroxytryptophan. Gastroenterology31, 188–195 (1958)
Wise, L., Burkholder, J., Zagaloff, A., Schuck, M., Bellinger, W. F.: Studies on the role of serotonin in the inhibition of gastric acid secretion by the duodenum. Ann. Surg.168, 824–830 (1968)
Resnick, R. H., Adelardi, C. F., Gray, S. J.: Stimulation of gastric secretion in man by a serotonin antagonist. Gastroenterology42, 22–25 (1962)
Hayes, J. R.: Stimulation of gastrin release by dopamine and serotonin. Scand. J. Gastroenterol.13 (Suppl. 49), 83 (1978) (Abstract)
Hierro, J. H., Sánchez, M. J., Peña, J.: Serotoninergic stimulation of gastrin secretion. Rev. Espan. Fisiol.34, 187–190 (1978)
Nandi Majumdar, A. P., Nakhla, A. M.: Effect of serotonin on protein synthesis in the stomach and serum gastrin concentration in rats. Scand. J. Gastroenterol.13, (Suppl. 49), 132 (1978) (Abstract)
Caldara, R., Ferrari, C., Romussi, M., Bierti, L., Gandini, S., Curtarelli, G.: Effect of dopamine infusion on gastric and pancreatic secretion and on gastrin release in man. Gut19, 724–728 (1978)
Faber, R. G., Hobsley, M.: Basal gastric secretion: reproductibility and relationship with duodenal ulceration. Gut18, 57–63 (1977)
Graham, J. R.: Current therapeutics. CCXXX. Methysergide. Practitioner198, 302–311 (1967)
Beretta, C., Ferrini, R., Glasser, A. H.: 1-methyl-8-beta-car-bobenzyloxy-amino-methyl-10-alpha-ergoline, a potent and long-lasting 5-hydroxytryptamine antagonist. Nature207, 421–422 (1965)
Creese, I., Burt, D. R., Snyder, S. H.: The dopamine receptor: differential binding of D-LSD and related agents to antagonist and agonist states. Life Sci.17, 1715–1720 (1975)
Greenberg, D. A., U'Prichard, D. C., Snyder, S. H.: Alpha-noradrenergic receptor binding in mammalian brain: differential labeling of agonist and antagonist states. Life Sci.19, 69–76 (1976)
Enjalbert, A., Hamon, M., Bourgoin, S., Bockaert, J.: Post-synaptic serotonin-sensitive adenylate cyclase in the central nervous system. II. Comparison with dopamine- and isoproterenol-sensitive adenylate cyclase in rat brain. Mol. Pharmacol.14, 11–23 (1978)
Ferrari, C., Caldara, R., Romussi, M., Rampini, P., Telloli, P., Zaatar, S., Curtarelli, G.: Prolactin suppression by serotonin antagonists in man: further evidence for serotoninergic control of prolactin secretion. Neuroendocrinology25, 319–328 (1978)
Eckert, H., Kiechel, J. R., Rosenthaler, J., Schmidt, R., Schreier, E.: Biopharmaceutical aspects. Analytical methods, pharmacokinetics, metabolism and bioavailability. In: Handbook of experimental pharmacology. Vol. IL. Ergot Alkaloids and Related Compounds. B. Berde and H. O. Schild (eds.), pp. 719–803. Berlin, Heidelberg, New York: Springer 1978
Baron, J. H.: The clinical use of gastric function tests. Scand. J. Gastroenterol.6 (Suppl. 9) (1970)
Haverback, R. J., Hogben, A. M., Moran, N. C., Terry, L. L.: Effect of serotonin (5-hydroxytryptamine) and related compounds on gastric secretion and intestinal motility in the dog. Gastroenterology32, 1058–1065 (1957)
Müller, E. E., Panerai, A. E., Cocchi, D., Mantegazza, P.: Endocrine profile of ergot alkaloids. Life Sci.21, 1545–1558 (1977)
Barth, H., Lorenz, W., Troidl, H.: Effect of amodiaquine on gastric histamine methyltransferase and on histamine-stimulated gastric secretion. Br. J. Pharmacol.55, 321–327 (1975)
Jacoby, H. I., Brodie, D. A.: Gastrointestinal actions of metoclopramide. An experimental study. Gastroenterology52, 676–684 (1967)
Caldara, R., Romussi, M., Ferrari, C.: Inhibition of gastrin secretion by sulpiride treatment in duodenal ulcer patients. Gastroenterology74, 221–223 (1978)
Spitaels, J. M., Moshal, M. G., Rawat, R., Pillay, K.: Effect of atropine and metoclopramide on serum gastrin response to protein in patients with duodenal ulcers. S. Afr. Med. J.52, 69–70 (1977)
Chiodini, P. G., Liuzzi, A., Müller, E. E., Botalla, L., Cremascoli, G., Oppizzi, G., Verde, G., Silvestrini, F.: Inhibitory effect of an ergoline derivative, metergoline, on growth hormone and prolactin levels in acromegalic patients. J. Clin. Endocrinol. Metab.43, 356–363 (1976)
Berkowitz, J. M., Warner, R. P., Janowitz, H. D., Miller, I. F.: Effects of some pharmacologic agents on gastric cation secretion: ratio of hydrogen to potassium ions. Proc. Soc. Exp. Biol. Med.135, 804–808 (1970)
Green, J. P., Maayani, S.: Tricyclic antidepressant drugs block histamine H2-receptor in brain. Nature269, 163–165 (1977)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Caldara, R., Ferrari, C., Barbieri, C. et al. Effect of two antiserotoninergic drugs, methysergide and metergoline, on gastric acid secretion and gastrin release in healthy man. Eur J Clin Pharmacol 17, 13–18 (1980). https://doi.org/10.1007/BF00561671
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00561671